Medications Prescribed After a Car Accident: Complete Guide

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 3, 2026 | 15 min read

A complete guide to every medication class prescribed after a car accident, organized by recovery phase. Covers NSAIDs, muscle relaxants, opioids, gabapentinoids, sleep aids, topical agents, SNRIs, CGRP antibodies, psychiatric medications, and GI protection -- with a typical treatment timeline and how pharmacy lien programs provide $0 upfront access.

Medications Prescribed After a Car Accident: Complete Guide

Medications prescribed after a car accident typically follow a three-phase progression: acute-phase drugs like NSAIDs, muscle relaxants, and short-course opioids in the first two to four weeks; subacute-phase additions such as gabapentinoids, sleep aids, and topical agents from weeks four through twelve; and chronic-phase therapies including SNRIs, CGRP antibodies, and long-acting anti-inflammatories when symptoms persist beyond three months. Understanding this progression helps patients, attorneys, and clinicians anticipate treatment changes and document injury severity throughout the case.

• Car accident prescriptions span at least six major drug classes and change as injuries evolve through acute, subacute, and chronic phases
• Each prescription change creates a clinical data point that documents worsening, new symptom onset, or treatment failure -- all valuable for the demand package
• LienScripts provides $0 upfront access to every medication class discussed in this guide through a pharmacy lien program available at over 70,000 pharmacies nationwide
• GI protection medications (PPIs or H2 blockers) are frequently co-prescribed with NSAIDs to prevent ulcers and bleeding
• LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report that maps every prescription to the clinical timeline, giving attorneys pharmacist-verified documentation for settlement negotiations

[!KEY] Car accident medication regimens are not static -- they evolve through distinct phases as injuries heal, new symptoms emerge, or initial treatments fail, and each prescription change serves as documented clinical evidence of the patient's condition.

Acute Phase (First 2-4 Weeks)

The acute phase begins at the emergency department or urgent care visit and extends through the first two to four weeks of treatment. During this period, the primary goals are controlling inflammation, managing pain, and addressing muscle spasm. Medications prescribed in this phase tend to be fast-acting and targeted at the immediate consequences of blunt-force trauma.

NSAIDs (Nonsteroidal Anti-Inflammatory Drugs)

NSAIDs are the cornerstone of acute car accident pain management. They reduce both pain and the inflammation driving that pain, making them more clinically appropriate than acetaminophen alone for most traumatic injuries.

Ketorolac deserves special mention because it is frequently administered in the emergency department by injection and provides NSAID-level pain relief comparable to some opioids. Its use is limited to five days due to GI and renal risks, but it is a powerful tool in the first 72 hours.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist with clinical experience in psychiatric pharmacy, explains, "The NSAID choice in the acute phase often dictates the entire downstream medication plan. A patient started on meloxicam in the ER, for example, frequently stays on that same agent for weeks because the prescriber sees it as the baseline anti-inflammatory. Attorneys should pay attention to which NSAID was chosen first and whether it was later escalated or switched, because those changes correlate directly with clinical worsening."

Muscle Relaxants

Muscle spasm is one of the most common acute symptoms after a car accident. The body's protective response to trauma is to tighten the muscles surrounding the injured area, which can cause severe stiffness and pain that compounds the underlying injury.

• Cyclobenzaprine (Flexeril): The most commonly prescribed muscle relaxant after car accidents. Typical dose is 5-10 mg at bedtime or three times daily. It causes significant drowsiness, which is why many prescribers limit it to bedtime use. Generally prescribed for two to four weeks.
• Methocarbamol (Robaxin): A less sedating alternative to cyclobenzaprine. Preferred for patients who need to remain functional during the day, such as those who must continue working. Typical dose is 750-1500 mg three to four times daily.
• Tizanidine (Zanaflex): Used when spasms are particularly severe or when cyclobenzaprine is not tolerated. Also causes drowsiness but works through a different mechanism (alpha-2 adrenergic agonist). Read more about tizanidine for neck spasms.

Opioid Analgesics (Short-Course for Severe Acute Pain)

Opioids are prescribed selectively in the acute phase for severe pain that does not respond adequately to NSAIDs and muscle relaxants alone. Modern prescribing guidelines emphasize short courses (typically three to seven days) and the lowest effective dose.

• Hydrocodone/Acetaminophen (Norco): The most commonly prescribed opioid combination after car accidents. Typical dose is 5-10 mg hydrocodone every four to six hours as needed. The acetaminophen component provides additional analgesic effect.
• Oxycodone/Acetaminophen (Percocet): Reserved for more severe acute pain. Same combination concept as hydrocodone but with a stronger opioid component. Less frequently prescribed as a first-line agent.
• Tramadol (Ultram): Sometimes used as a lower-potency alternative, though it carries its own risks including seizure threshold reduction and serotonin interactions.

[!KEY] Opioid prescriptions in a car accident case are not evidence of drug-seeking behavior -- they are clinical evidence of pain severity. A prescriber documents objective findings before writing an opioid prescription, and the duration and dose changes tell a story about the injury's trajectory.

Acetaminophen

Acetaminophen (Tylenol) is frequently used as an adjunct to NSAIDs, particularly for patients who cannot tolerate higher NSAID doses. Maximum daily dose is 3000-4000 mg depending on liver function and other medications. It provides analgesic effect without anti-inflammatory activity.

Subacute Phase (Weeks 4-12)

The subacute phase marks a clinical transition. Acute inflammation is resolving, but new symptoms may be emerging. This is the phase where nerve pain, sleep disruption, and mood changes become clinically significant, and the medication regimen expands to address these evolving complaints.

Gabapentinoids for Nerve Symptoms

When patients develop radiculopathy (radiating nerve pain), paresthesias (tingling or numbness), or allodynia (pain from normally non-painful stimuli), gabapentinoids become a critical addition to the treatment plan. These symptoms typically emerge two to six weeks after the accident as swelling around nerve roots peaks or as disc herniations begin to compress neural structures.

• Gabapentin (Neurontin): First-line gabapentinoid for neuropathic pain. Started at 100-300 mg at bedtime and titrated over two to four weeks to a therapeutic dose of 900-3600 mg daily in divided doses. The slow titration is medically necessary to minimize drowsiness and dizziness.
• Pregabalin (Lyrica): Used when gabapentin is ineffective or not tolerated, or when a faster onset is needed. Pregabalin has better bioavailability and a more predictable dose-response curve. Typical starting dose is 75 mg twice daily, titrated to 150-300 mg twice daily.

The addition of a gabapentinoid to the medication regimen is a clinically significant event. It documents that the treating physician identified nerve involvement -- a finding that elevates the injury beyond simple muscular strain.

Sleep Aids for Post-Traumatic Sleep Disruption

Sleep disruption after a car accident is extremely common and clinically significant. Poor sleep impairs tissue healing, increases pain sensitivity, and worsens mood -- creating a cycle that slows recovery.

• Trazodone: The most commonly prescribed sleep medication in the personal injury context. At low doses (25-100 mg at bedtime), trazodone promotes sleep onset and maintenance without the dependence risk of benzodiazepines. It also has mild antidepressant properties that can help with post-accident mood changes.
• Zolpidem (Ambien): Sometimes prescribed for short-term use when sleep disruption is severe. Generally limited to two to four weeks due to dependence concerns.

Topical Agents

Topical medications become increasingly important in the subacute phase because they deliver targeted relief without the systemic side effects of oral medications. This allows prescribers to reduce oral NSAID doses while maintaining pain control.

• Lidocaine patches (Lidoderm): 5% lidocaine patches applied to the painful area for 12 hours on, 12 hours off. Particularly effective for localized neck, back, and shoulder pain. No systemic absorption concerns at recommended doses.
• Diclofenac gel (Voltaren): Topical NSAID applied directly to painful joints or muscles. Provides anti-inflammatory effect at the site of injury with minimal systemic exposure. Commonly used for knee, elbow, and wrist injuries.
• Compounded topical creams: Some prescribers order custom-compounded creams containing combinations of ketamine, gabapentin, lidocaine, and anti-inflammatories. Learn more about compound medications in personal injury.

[!KEY] The transition from oral-only to topical-plus-oral medication management in the subacute phase is a hallmark of appropriate clinical care -- it shows the prescriber is actively optimizing the regimen to balance efficacy against side effect risk.

Chronic Phase (3+ Months Post-Accident)

When symptoms persist beyond three months, the clinical picture shifts from acute injury management to chronic pain treatment. This phase requires different medication strategies because the underlying pain mechanisms have changed. Central sensitization, where the nervous system amplifies pain signals even as tissues heal, becomes a primary driver of ongoing symptoms.

SNRIs for Chronic Pain and Depression

Serotonin-norepinephrine reuptake inhibitors (SNRIs) serve a dual purpose in chronic post-accident care: they treat both chronic pain and the depression or anxiety that frequently accompanies prolonged injury.

• Duloxetine (Cymbalta): FDA-approved for chronic musculoskeletal pain, making it a well-documented choice in the personal injury context. Typical dose starts at 30 mg daily for one week, then increases to 60 mg daily. Duloxetine is particularly effective for patients who have both persistent pain and mood symptoms -- a combination that is extremely common in chronic post-accident cases.

CGRP Antibodies for Persistent Post-Traumatic Migraines

Post-traumatic headaches are one of the most common complaints after car accidents, particularly those involving whiplash or head impact. When these headaches persist beyond three months and meet migraine criteria, CGRP (calcitonin gene-related peptide) monoclonal antibodies may be prescribed.

• Erenumab (Aimovig), Fremanezumab (Ajovy), Galcanezumab (Emgality): These injectable medications are administered monthly or quarterly and work by blocking CGRP, a protein involved in migraine pathways. They represent a significant treatment escalation and document that post-traumatic headaches have become chronic and debilitating. See the detailed comparison of Aimovig vs. Ajovy vs. Emgality.

Psychiatric Medications for PTSD and Anxiety

Motor vehicle accidents are a leading cause of post-traumatic stress disorder (PTSD) in the civilian population. When PTSD or significant anxiety develops, psychiatric medications become a necessary component of comprehensive care.

• SSRIs (sertraline, paroxetine): First-line medications for PTSD. Sertraline (Zoloft) and paroxetine (Paxil) are the only two SSRIs with FDA approval specifically for PTSD treatment. Typical doses are higher than those used for depression alone.
• Prazosin: An alpha-1 blocker used off-label for PTSD-related nightmares. Prescribed at bedtime, starting at 1 mg and titrated to 2-15 mg based on response. The presence of prazosin in a medication record is strong documentation of trauma-related sleep disturbance.
• Hydroxyzine: A non-addictive anxiolytic used for situational anxiety, such as driving anxiety that develops after an accident. Prescribed 25-50 mg as needed.

Long-Acting NSAIDs for Chronic Inflammation

When ongoing inflammation requires NSAID therapy beyond the acute phase, prescribers often switch to long-acting formulations that provide consistent anti-inflammatory coverage with once-daily dosing.

• Meloxicam (Mobic): 7.5-15 mg once daily. Preferred for chronic use due to its favorable GI safety profile compared to ibuprofen or naproxen. Often becomes the sole NSAID when patients transition off multiple acute-phase medications.
• Celecoxib (Celebrex): 100-200 mg once or twice daily. A COX-2 selective NSAID with lower GI risk than non-selective NSAIDs, making it a preferred choice for patients who need long-term anti-inflammatory therapy or who have a history of GI problems.

GI Protection: Preventing NSAID Complications

Extended NSAID use -- whether for weeks or months -- carries a well-documented risk of gastrointestinal complications including ulcers, bleeding, and erosive gastritis. Responsible prescribers address this risk proactively by co-prescribing GI-protective agents.

GI protection is especially important for patients who are also taking corticosteroids, anticoagulants, or who have a history of GI problems. The co-prescription of a PPI alongside an NSAID is standard of care and should not be viewed as an unnecessary medication -- it is a necessary safety measure.

How Medications Change Over Time

Car accident medication regimens are dynamic. The following table illustrates a typical progression for a patient with moderate injuries:

What Triggers Medication Changes

Medication changes in a car accident case are never arbitrary. Each change reflects a clinical decision driven by one of the following:

• New symptom onset: A patient who initially had only back pain develops radiating leg pain at week three, prompting the addition of gabapentin. This documents injury progression.
• Imaging results: An MRI showing a disc herniation triggers a Medrol dose pack (methylprednisolone taper) and escalation to pregabalin. The imaging-to-prescription connection is powerful evidence.
• Failed treatment trials: A patient who does not respond to gabapentin is switched to pregabalin. The documented trial-and-failure demonstrates treatment complexity.
• Side effects: A patient develops GI symptoms on naproxen, prompting a switch to celecoxib plus omeprazole. This documents both the injury requiring ongoing NSAID use and the complication from treatment.
• Functional milestones: As physical therapy progresses and function improves, the prescriber begins tapering medications. This documents recovery trajectory.

[!KEY] Every medication change in a car accident case is a documented clinical event. When mapped chronologically, the prescription record tells the complete story of the injury -- from acute trauma through recovery or chronic management -- in a format that is objective, timestamped, and verifiable through pharmacy dispensing records.

Pharmacy Lien Coverage: $0 Upfront Access to Every Medication Class

Every medication discussed in this guide -- from acute-phase opioids to chronic-phase CGRP antibodies -- is available at $0 upfront cost through the LienScripts pharmacy lien program. LienScripts covers all medication classes for personal injury patients, ensuring that treatment decisions are driven by clinical need rather than financial constraints.

The LienScripts program works with over 70,000 pharmacies nationwide, meaning patients fill prescriptions at their local pharmacy with no out-of-pocket cost. The medication cost is recovered from the settlement at case resolution, ensuring zero treatment gaps from financial barriers.

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages. The MERIT report maps every prescription to the clinical timeline, documents medication changes and their clinical rationale, and provides a comprehensive pharmacy narrative that strengthens the demand package.

For attorneys, the MERIT report transforms raw pharmacy dispensing data into a clinical narrative that supports causation, documents injury severity, and quantifies the pharmaceutical component of damages. For patients, LienScripts eliminates the single largest barrier to medication adherence: cost.

Related Resources

• Pain Management After a Car Accident: A Complete Timeline -- Phase-by-phase guide to pain recovery after a car accident
• Gabapentin for Whiplash -- Deep dive into gabapentin prescribing for whiplash nerve pain
• Hydrocodone for Severe Pain After an Accident -- What patients and attorneys should know about opioid use in acute injury
• Duloxetine for Chronic Pain After an Accident -- How SNRIs address both chronic pain and depression after trauma
• Omeprazole and NSAID Protection -- Why GI protection is essential during extended NSAID therapy
• Cyclobenzaprine After a Rear-End Collision -- Muscle relaxant prescribing patterns after car accidents